IntelGenx Corp. Announces Equity Analyst Coverage By H.C. Wainwright

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAINT LAURENT, Quebec, July 1, 2014 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) today announced that H.C. Wainwright has initiated equity analyst coverage of IntelGenx.

H.C. Wainwright initiated coverage of IntelGenx with a “buy” rating and price target of $2. The stock closed at US$0.70 on the OTCQX and at CAD$0.74 on the TSX-V last Friday.

A copy of the initiation report can be accessed by clicking: https://hcwco.bluematrix.com/docs/pdf/ff51024b-71e2-47c5-ab58-7d05118ab4aa.pdf.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC